Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis

Insulin therapy is frequently required to achieve glycemic targets (A1c) in type 2 diabetes (T2D); however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, such as V-Go, may simplify and optimize this complexity....

Descripción completa

Detalles Bibliográficos
Autores principales: Zeidan, Trisha, Nikkel, Carla, Dziengelewski, Beth, Wu, Stephanie, Chen, Aleda M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712908/
https://www.ncbi.nlm.nih.gov/pubmed/33202616
http://dx.doi.org/10.3390/pharmacy8040215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712908/
https://www.ncbi.nlm.nih.gov/pubmed/33202616
http://dx.doi.org/10.3390/pharmacy8040215

Ejemplares similares